Legal & General Group Plc Makes New Investment in Addus HomeCare Corporation $ADUS

Key Points

• Legal & General Group Plc acquired 45,097 shares of Addus HomeCare in the second quarter, worth approximately $4.5 million, giving it a 0.24% stake. Institutional investors collectively own 95.35% of the company.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $128.86. Royal Bank of Canada raised its target to $134, while Barclays maintained an underweight rating.
• Addus HomeCare exceeded quarterly expectations, reporting earnings of $1.73 per share versus a $1.70 consensus estimate and revenue of $377.41 million, up 8% year over year.

Legal & General Group Plc bought a new position in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 45,097 shares of the company's stock, valued at approximately $4,531,000. Legal & General Group Plc owned 0.24% of Addus HomeCare as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. Royal Bank of Canada grew its position in shares of Addus HomeCare by 24.3% during the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company's stock valued at $682,000 after buying an additional 1,347 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Addus HomeCare by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company's stock worth $1,026,000 after acquiring an additional 459 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Addus HomeCare by 6.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company's stock valued at $5,111,000 after acquiring an additional 2,952 shares during the period. Jane Street Group LLC boosted its stake in Addus HomeCare by 387.6% in the first quarter. Jane Street Group LLC now owns 11,045 shares of the company's stock valued at $1,092,000 after acquiring an additional 8,780 shares during the period. Finally, Intech Investment Management LLC grew its holdings in shares of Addus HomeCare by 44.7% during the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company's stock valued at $1,420,000 after purchasing an additional 4,439 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Weiss Ratings raised Addus HomeCare from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, July 9th. Royal Bank Of Canada increased their target price on Addus HomeCare from $130.00 to $134.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 5th. Citizens Jmp reiterated a "market outperform" rating and issued a $142.00 target price on shares of Addus HomeCare in a research note on Monday, May 18th. Citigroup reissued a "market outperform" rating on shares of Addus HomeCare in a report on Friday, July 24th. Finally, Barclays upped their price target on shares of Addus HomeCare from $92.00 to $96.00 and gave the stock an "underweight" rating in a research report on Wednesday, July 8th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $128.86.

Insider Buying and Selling at Addus HomeCare

In related news, insider Heather Dixon sold 288 shares of the company's stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the sale, the insider owned 44,371 shares of the company's stock, valued at $4,160,668.67. This represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is currently owned by corporate insiders.

Addus HomeCare Stock Performance

Shares of NASDAQ ADUS opened at $118.69 on Friday. Addus HomeCare Corporation has a 12-month low of $87.95 and a 12-month high of $124.43. The company has a market cap of $2.22 billion, a PE ratio of 20.82, a P/E/G ratio of 1.58 and a beta of 0.86. The stock has a 50 day simple moving average of $113.57 and a 200-day simple moving average of $103.09. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.05.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its earnings results on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, beating the consensus estimate of $1.70 by $0.03. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.The firm had revenue of $377.41 million for the quarter, compared to the consensus estimate of $376.24 million. During the same quarter in the previous year, the business earned $1.49 EPS. The firm's revenue for the quarter was up 8.0% on a year-over-year basis. On average, equities research analysts forecast that Addus HomeCare Corporation will post 6.3 EPS for the current year.

Addus HomeCare Company Profile

Addus HomeCare NASDAQ: ADUS is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.

The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source